Inflammatory Breast Cancer (IBC)

Also known as: Inflammatory carcinoma of the breast / Inflammatory Breast Cancer / Inflammatory carcinoma of breast (disorder) / Inflammatory Breast Neoplasms / Breast carcinoma inflammatory

DrugDrug NameDrug Description
DB06205Hyaluronidase (human recombinant)An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.
DB06366PertuzumabAn antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents.
DB00072TrastuzumabA monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.
DrugDrug NamePhaseStatusCount
DB11059Carboxymethylcellulose0Completed1
DB00123Lysine0Completed1
DB00112Bevacizumab1Unknown Status1
DB00958Carboplatin1Completed1
DB00531Cyclophosphamide1Unknown Status1
DB01248Docetaxel1Unknown Status1
DB15631Edodekin alfa1Completed1
DB00445Epirubicin1Unknown Status1
DB00544Fluorouracil1Unknown Status1
DB15721Natural Killer Cell1Completed1
DB01229Paclitaxel1Completed1
DB15408Silmitasertib1Unknown Status1
DB00072Trastuzumab1Completed1
DB00072Trastuzumab1Unknown Status1
DB00062Albumin human1 / 2Terminated1
DB01229Paclitaxel1 / 2Terminated1
DB06176Romidepsin1 / 2Terminated1
DB00062Albumin human2Active Not Recruiting1
DB00041Aldesleukin2Completed1
DB01008Busulfan2Completed1
DB00958Carboplatin2Active Not Recruiting1
DB00958Carboplatin2Completed1
DB00515Cisplatin2Completed1
DB00531Cyclophosphamide2Active Not Recruiting2
DB00531Cyclophosphamide2Completed3
DB00531Cyclophosphamide2Recruiting1
DB06643Denosumab2Completed1
DB00997Doxorubicin2Active Not Recruiting2
DB00997Doxorubicin2Completed2
DB00445Epirubicin2Completed1
DB00445Epirubicin2Recruiting1
DB08871Eribulin2Active Not Recruiting1
DB00099Filgrastim2Completed2
DB01042Melphalan2Completed1
DB01229Paclitaxel2Active Not Recruiting2
DB01229Paclitaxel2Completed3
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Completed1
DB08877Ruxolitinib2Active Not Recruiting1
DB00020Sargramostim2Completed1
DB01268Sunitinib2Completed1
DB00675Tamoxifen2Completed1
DB04572Thiotepa2Completed1
DB04960Tipifarnib2Completed1
DB00072Trastuzumab2Completed1
DB00112Bevacizumab2 / 3Completed1
DB00958Carboplatin2 / 3Completed1
DB00515Cisplatin2 / 3Active Not Recruiting1
DB00515Cisplatin2 / 3Completed1
DB00997Doxorubicin2 / 3Completed1
DB00644Gonadorelin2 / 3Active Not Recruiting1
DB01259Lapatinib2 / 3Completed1
DB01006Letrozole2 / 3Active Not Recruiting1
DB01229Paclitaxel2 / 3Active Not Recruiting1
DB01229Paclitaxel2 / 3Completed1
DB00958Carboplatin3Completed1
DB00515Cisplatin3Recruiting1
DB00531Cyclophosphamide3Completed2
DB00531Cyclophosphamide3Recruiting1
DB00531Cyclophosphamide3Terminated1
DB00380Dexrazoxane3Terminated1
DB01248Docetaxel3Completed1
DB00997Doxorubicin3Completed1
DB00997Doxorubicin3Terminated1
DB00445Epirubicin3Completed2
DB00445Epirubicin3Recruiting1
DB08917Ferric carboxymaltose3Completed1
DB15763Iron polymaltose3Completed1
DB01229Paclitaxel3Completed2
DB01229Paclitaxel3Recruiting1
DB01229Paclitaxel3Terminated1
DB06366Pertuzumab3Completed1
DB00675Tamoxifen3Terminated1
DB00072Trastuzumab3Completed1
DB00072Trastuzumab3Terminated1